Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection

NCT00734162

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Children's Hospital & Research Center at Oakland Oakland, California, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Children's Hospital & Regional Medical Center, d/b/a Seattle Children's Research Institute Seattle, Washington, United States
  • Multiprofile Hospital for Active Treatment Sveti Georgi Plovdiv, Bulgaria
View all 21 locations
View Trial Details
Completed

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

NCT01215643

Conditions
Blood-Borne Infections, Chronic Pain, Communicable Diseases, +13 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • Sharp Rees-Stealy Medical Group, Inc. San Diego, California, United States
  • Research and Education Inc. San Diego, California, United States
  • Island View Gastroenterology Associates Ventura, California, United States
View all 73 locations
View Trial Details
Completed

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

NCT01399619

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1220.19.0045 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1220.19.0007 Boehringer Ingelheim Investigational Site Palm Springs, California, United States
  • 1220.19.0031 Boehringer Ingelheim Investigational Site San Francisco, California, United States
  • 1220.19.0005 Boehringer Ingelheim Investigational Site Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details

Related conditions